SEC Comment Letter 0000000000-23-009732 to Comera Life Sciences Holdings, Inc. (CMRA) (CIK 0001907685)
Comera Life Sciences Holdings, Inc. (CMRA) (CIK 0001907685)
Date: Sept. 1, 2023 · CIK: 0001907685 · Accession: 0000000000-23-009732
AI Filing Summary & Sentiment
File numbers found in text: 333-274253
Letter
United States securities and exchange commission logo September 1, 2023 Jeffrey S. Hackman Chief Executive Officer Comera Life Sciences Holdings, Inc. 12 Gill Street, Suite 4650 Woburn, MA 01801 Re:Comera Life Sciences Holdings, Inc. Registration Statement on Form S-3 Filed August 29, 2023 File No. 333-274253 Dear Jeffrey S. Hackman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Ryan M. Rourke Reed, Esq.
Show Raw Text
United States securities and exchange commission logo
September 1, 2023
Jeffrey S. Hackman
Chief Executive Officer
Comera Life Sciences Holdings, Inc.
12 Gill Street, Suite 4650
Woburn, MA 01801
Re:Comera Life Sciences Holdings, Inc.
Registration Statement on Form S-3
Filed August 29, 2023
File No. 333-274253
Dear Jeffrey S. Hackman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Ryan M. Rourke Reed, Esq.